Wealth Enhancement Advisory Services’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
Wealth Enhancement Advisory Services's AGIO Position: Q3 2026 in Review
Wealth Enhancement Advisory Services increased its Agios Pharmaceuticals (AGIO) stake by 7% in Q3 2026, buying an estimated $43.7K and bringing the position to 19,208 shares worth $613K. The position accounts for ﹤0.01% of the portfolio, ranked #2615.
Wealth Enhancement Advisory Services first reported a position in AGIO in Q2 2026 and has held it in 2 quarters since. The position peaked at $740K in Q2 2026. 241 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.
- Wealth Enhancement Advisory Services held 19,208 shares of Agios Pharmaceuticals worth $613K as of Q3 2026.
- Wealth Enhancement Advisory Services bought 1,249 Agios Pharmaceuticals shares in Q3 2026, an estimated $43.7K.
- Agios Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #2615 holding.
- Wealth Enhancement Advisory Services first reported a position in Agios Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- Wealth Enhancement Advisory Services's Agios Pharmaceuticals position peaked at $740K in Q2 2026.
- 241 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.